Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06462950

Experiment Among Smokers in Which Two Variables Are Manipulated: Ostracism and Concealability

Study 3: The Experimental Examination of Ostracism and Concealability on Gendered Stigma Smoking Outcomes

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
340 (estimated)
Sponsor
Dickinson College · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this experimental study is to learn about the effects of ostracism and concealment among adult smokers. The main aims are: 1. Determine the causal consequences of gendered stigmatization. Specifically, do women react more strongly than men to exclusion (as opposed to inclusion) especially when their gender is revealed (as opposed to concealed) for outcomes such as smoking stigma, stress, cognitive depletion, smoking attitudes, and smoking cessation intentions (Study 3)? 2. Examine the moderating roles of cultural context. Specifically, contrasting the cultural context in the US and Denmark (where gender norms are more egalitarian) do Danish smokers show fewer gender differences than US smokers in how they describe and react to their smoking stigmatization experiences (Study 1, 2, and 3)?

Detailed description

The proposed studies examine cross-culturally the reasons why among smokers, women feel more stigmatized than men do. An experiment with US and Danish smokers will examine how men and women differ in their reactions to being stigmatized (using a standard exclusion manipulation) when their gender is revealed instead of concealed. The outcome measures will include stress, smoking stigma, cognitive depletion, smoking attitudes, and smoking cessation intentions.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDo men and women differ in their reactions to the experimental conditions.Do men and women differ in their reactions to the experimental conditions.

Timeline

Start date
2028-05-01
Primary completion
2028-07-01
Completion
2028-12-01
First posted
2024-06-17
Last updated
2024-06-17

Source: ClinicalTrials.gov record NCT06462950. Inclusion in this directory is not an endorsement.